These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 17373960)
1. Brain natriuretic peptide detects cardiac abnormalities in mass screening. Takase H; Toriyama T; Sugiura T; Takahashi A; Sugiyama M; Ohashi M; Ueda R; Dohi Y Eur J Clin Invest; 2007 Apr; 37(4):257-62. PubMed ID: 17373960 [TBL] [Abstract][Full Text] [Related]
2. B-type natriuretic peptide testing for structural heart disease screening: a general population-based study. Nakamura M; Tanaka F; Sato K; Segawa T; Nagano M J Card Fail; 2005 Dec; 11(9):705-12. PubMed ID: 16360967 [TBL] [Abstract][Full Text] [Related]
3. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide]. Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693 [TBL] [Abstract][Full Text] [Related]
4. Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides. Ng LL; Loke IW; Davies JE; Geeranavar S; Khunti K; Stone MA; Chin DT; Squire IB J Am Coll Cardiol; 2005 Apr; 45(7):1043-50. PubMed ID: 15808762 [TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides in patients with atrial fibrillation. Wozakowska-Kapłon B; Opolski G; Herman Z; Kosior D Cardiol J; 2008; 15(6):525-9. PubMed ID: 19039756 [TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children. Aggarwal S; Pettersen MD; Bhambhani K; Gurczynski J; Thomas R; L'Ecuyer T Pediatr Blood Cancer; 2007 Nov; 49(6):812-6. PubMed ID: 17171687 [TBL] [Abstract][Full Text] [Related]
8. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study. de Lemos JA; McGuire DK; Khera A; Das SR; Murphy SA; Omland T; Drazner MH Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205 [TBL] [Abstract][Full Text] [Related]
15. The concentration of atrial and brain natriuretic peptide in patients with idiopathic hypertension. Irzmanski R; Barylski M; Banach M; Piechota M; Kowalski J; Cierniewski C; Pawlicki L Med Sci Monit; 2007 Oct; 13(10):CR449-56. PubMed ID: 17901852 [TBL] [Abstract][Full Text] [Related]
16. Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations. Oyama MA; Sisson DD; Solter PF Am J Vet Res; 2007 Jan; 68(1):42-7. PubMed ID: 17199417 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation. Moreira Mda C; Heringer-Walther S; Wessel N; Moreira Ventura T; Wang Y; Schultheiss HP; Walther T Cardiology; 2008; 110(4):217-25. PubMed ID: 18073475 [TBL] [Abstract][Full Text] [Related]